Emergex Announces Authorisation from Philippines FDA to Initiate Phase I-II Clinical Trial of CoronaTcP™

Emergex received authorisation from the Philippines FDA to launch a Phase I-II clinical trial of CoronaTcP, its T cell-priming immune set-point ca...

Related Keywords

Philippines ,United States ,Pennsylvania ,Switzerland ,United Kingdom ,Rachelle Babb ,Storme Moore Thornicroft ,Thomas Rademacher ,Twitter ,Linkedin ,Philippines Food Drug Administration ,Emergex Vaccines Holding Limited ,Vaccines Holding Limited ,Philippines Food ,Drug Administration ,Chief Executive Officer ,Dengue Fever ,Universal Influenza ,Senior Account ,